Clinical Research Directory
Browse clinical research sites, groups, and studies.
Weight Loss in Adults Using Semaglutide (Real-world Study)
Sponsor: Novo Nordisk A/S
Summary
The purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.
Official title: Real-world Weight Outcomes in Adults Treated With Semaglutide s.c. 1.0 mg or 1.7 mg for Weight Management: a Non-interventional Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
237211
Start Date
2026-05-12
Completion Date
2026-06-15
Last Updated
2026-09-04
Healthy Volunteers
No
Conditions
Interventions
Semaglutide
This is a retrospective, non-interventional study; therefore, no intervention was administered as part of the study.
Locations (2)
Novo Nordisk Investigational Site
Seattle, Washington, United States
Novo Nordisk Investigational Site
London, United Kingdom